baber/WOPTO huggingface dataset:
Patent AU-2019352501-A1 (AU)
Title: Permanent isolation system for hazardous waste in a geological repository
Inventor: HOSKING STEPHEN
IPC: B09B1/00
Filed: 2019-10-01
Abstract: A geological repository adapted for permanent isolation of hazardous waste and a method permanently isolating hazardous waste from the biosphere are disclosed. The geological repository includes a near surface void having side walls and a floor disposed in a geologically stable formation. The geologically stable formation is selected to have low permeability, thereby providing a barrier to ingress of groundwater. The repository is provided with a ramp to the floor of the void for movement of hazardous material transporting vehicles and an inflatable cover configured to provide a barrier between the void and the surface environment. The inflatable cover has a flexible top layer adapted to extend over the entire area of said void and outer edge elements which form a plurality of skirt flaps disposed along its perimeter. An anchor is used to secure said skirt flaps to a surface perimeter of said void so as to maintain a seal between the inflatable cover and said void. One or more sealable access hatches are provided in the inflatable cover to allow access of personnel and hazardous material transporting vehicles between said void and the surface environment. The repository is also provided with a fan for inflating the inflatable cover.
Patent AU-2019370339-A1 (AU)
Title: Bispecific antibody and use thereof
Inventor: LI QIANG
IPC: A61P35/02
Filed: 2019-09-26
Abstract: A bispecific antibody, which specifically binds the surface antigen CD3 of immune cells and the BCMA antigen on the surface of tumor cells and which may bind to human CD3 with high affinity, induce T cell proliferation, and mediate tumor cell killing effects. The bispecific antibody may be used to mediate the T cell-specific killing of target cells in in vitro tests. The method for constructing a bispecific antibody is simple, and avoids the possibility of mismatching between two sets of light chains and heavy chains of a heterologous bispecific antibody, thus the difficulty of antibody purification is reduced, the affinity of the obtained antibody is high, the side effects of induced cytokines are few, and safety is high.
Patent AU-2019376078-A1 (AU)
Title: CDCP1-targeted therapies
Inventor: CANTLEY LEWIS C
IPC: A61K39/395
Filed: 2019-11-07
Abstract: The present disclosure provides materials and methods for CUB domain-containing protein 1 (CDCPl)-targeted therapy.
Patent AU-2019472431-A1 (AU)
Title: Method for reducing stick-slip in logging tools
Inventor: LUDWIG WESLEY NEIL
IPC: E21B23/14
Filed: 2019-10-30
Abstract: The disclosure provides a method of obtaining logging data of subterranean formations and a logging system for doing the same. One example method includes: (1) conveying a logging tool and downhole tractor through a gravity-conveyed section of a borehole, and (2) obtaining logging data from the logging tool during the conveying, wherein the downhole tractor is employed for at least a portion of the obtaining of the logging data. Another example method includes: (1) lowering a logging tool and an open-hole tractor through a gravity conveyed section of an open borehole, (2) raising the logging tool and the open-hole tractor through the gravity conveyed section, (3) obtaining, from the logging tool during the raising, logging data associated with the gravity conveyed section of the open borehole, and (4) employing the open-hole tractor for at least a portion of the raising of the logging tool during the obtaining.
Patent AU-2020201369-A1 (AU)
Title: Synthesis of polycyclic-carbamoylpyridone compounds
Inventor: CHIU ANNA
IPC: C07C237/16
Filed: 2020-02-25
Abstract: C:\Interwo n\NRPortbl\DCC\SXD\17528963_I.docx-13/08/2018 Lrl H (Hal), 5 Methods of making compounds of Formula (I) are disclosed.
Patent AU-2020201820-A1 (AU)
Title: Human CD30 ligand antigen binding proteins
Inventor: ANDERSEN METTE DAHL
IPC: C07K16/28
Filed: 2020-03-12
Abstract: Provided are compositions and methods relating to human CD30L antigen binding proteins. Compositions described herein include: human CD30L antigen binding proteins, polynucleotides encoding human CD30L antigen binding proteins, vectors comprising these polynucleotides, host cells, and pharmaceutical compositions. Methods of making and using each of these compositions are also provided.
Patent AU-2020202014-A1 (AU)
Title: Raw sensor input encryption for passcode entry security
Inventor: QUIGLEY OLIVER S
IPC: G06F21/30
Filed: 2020-03-19
Abstract: Abstract A method of encrypting sensor input entries for passcode entry security is disclosed. The method in one embodiment includes presenting a passcode entry interface on an electronic device for a user to input a passcode entry. The electronic device then receives an input event, which is indicative of at least part of the passcode entry by the user, from a sensor of the electronic device. The electronic device then encrypts a sensor value of the input event and transmits the encrypted sensor value to an external system over a network to cause the external system to decipher the passcode entry from the encrypted sensor value.
Patent AU-2020202465-A1 (AU)
Title: Sheet processing apparatus and foreign-object entry determination method
Inventor: GOKURAKUJI TAIKI
IPC: G07D11/13
Filed: 2020-04-09
Abstract: A sheet processing apparatus (1) includes a plurality of coils that are provided in a 
feeding section which feeds a sheet that has been taken in into a transport path and that 
generate magnetic fields and a control section that determines, on the basis of differential 
5 values between signals output from the plurality of coils, whether a foreign object has 
entered the feeding section.
1/10 
13 
15c 
14 12 15b 
15d 15 16 18 
1 15a 
11 
155 
25
4 15g 
5 20 
21 
33 
30 
23 24 26 27 28 
uP 
FRONT BACK 
DOWN 
FIG. 1
Patent AU-2020206353-A1 (AU)
Title: Reconfigurable living space
Inventor: ZAIL NOLAN
IPC: E04B1/82
Filed: 2020-01-09
Abstract: A living space is disclosed including one or more reconfigurable rooms. A room may be made reconfigurable by including a first wall that is configured to expand and retract along its length, and to move in a first direction orthogonally to its length. The room may also be configurable by including a second wall configured to expand and retract along its length, and to move in a second direction orthogonally to its length. The reconfigurable room may further include movable furniture placed in different positions, depending on a configuration of the room.
Patent AU-2020210130-A1 (AU)
Title: β-galactosidase alpha peptide as a non-antibiotic selection marker and uses thereof
Inventor: PERRY WILLIAM
IPC: C12N15/63
Filed: 2020-01-14
Abstract: Provided herein are methods of using a nucleic acid construct as a selectable marker. The nucleic acid construct comprises an isolated β-galactosidase expression cassette comprising a nucleic acid sequence encoding the amino-terminal fragment of β- galactosidase operably linked to a promoter. Also provided are isolated vectors comprising the β-galactosidase expression cassette, methods of generating the isolated vector, and kits comprising the isolated vector.
Patent AU-2020212041-A1 (AU)
Title: Home emergency guidance and advisement system
Inventor: DERICKSON RUSSELL G
IPC: G08B7/06
Filed: 2020-01-24
Abstract: An emergency guidance and advisement system is provided to automatically determine a floor map of a building and using the floor map for advising how to exit the building during an emergency, such as a fire. The system can automatically create an escape plan, based on pre-disaster and in-disaster motion detection of users within the home, and provide dynamic advisement to guide users out of the home during an emergency.
Patent AU-2020217716-A1 (AU)
Title: Membrane protein scaffolds for exosome engineering
Inventor: DOOLEY KEVIN P
IPC: C12N15/88
Filed: 2020-02-04
Abstract: The present disclosure relates to heterologous exosomal vesicle proteins (HEVPs), engineered exosomes comprising HEVPs, and methods of preparing and using these compositions, including therapeutic applications.
Patent AU-2020222942-A1 (AU)
Title: Terminal assembly for an electric vehicle charger, charger and method of manufacturing of both
Inventor: NAESJE KJETIL
IPC: H02J7/00
Filed: 2020-02-17
Abstract: A terminal assembly (1) for an electric vehicle charger (100) is described, the charger comprising a connector socket (110) configured for receiving an electric plug from a charging cable, the connector socket (110) having a plurality of power output pins (3), wherein the terminal assembly (1) comprises: - the plurality of power output pins (3); - a plurality of conductors (4, 4-1) for connecting the power output pins (3) to a printed circuit board (2); and - a support unit (5) for receiving the conductors (4, 4-1) and for arranging and holding the conductors (4, 4-1) in a fixed position relative to each other, the terminal assembly (1) being mountable directly onto the printed circuit board (2). An electric vehicle charger (100) comprising the terminal assembly (1) is also described as well as methods for manufacturing of the terminal assembly (1) and of the electric vehicle charger (100).
Patent AU-2020233778-A1 (AU)
Title: Mechanism of urea/solid acid interaction under storage conditions and storage stable solid compositions comprising urea and acid
Inventor: ANDERSON DERRICK
IPC: C11D1/12
Filed: 2020-09-18
Abstract: MECHANISMOF UREA/SOLIDACIDINTERACTIONUNDER 
STORAGE CONDITIONS AND STORAGE STABLE SOLID 
COMPOSITIONS COMPRISING UREA AND ACID 
ABSTRACT 
Solid rinsing, cleaning and/or sanitizing compositions for various applications are 
provided. In particular, solid compositions include a complex of urea and an acid having 
desirable storage stability previously unavailable in solid urea/acid compositions. Stable 
solid compositions are disclosed and methods of making the same to overcome 
conventional limitations associated with forming kinetically and thermodynamically stable 
solids that utilize urea/acid compositions.  
AH26(25972771 1):RTK
Patent AU-2020241843-A1 (AU)
Title: Arrival detection for battery-powered optical sensors
Inventor: GREEN KELBY
IPC: G06Q10/00
Filed: 2020-03-16
Abstract: A method including, accessing an occupancy of the workspace. The method also includes, in response to the occupancy status indicating vacancy: at a first time, recording a first image and a second image of the workspace, the first image and the second image characterized by a first resolution; and executing an arrival detection model based on the first and second image. The method further includes, in response to detecting arrival at the workspace: at a third time, recording a third image of the workspace, the third image characterized by a second resolution greater than the first resolution; and executing an occupancy detection model based on the third image. The method additionally includes, in response to detecting occupancy of the workspace: updating the occupancy status to indicate occupancy; and transmitting the occupancy status to a remote scheduling system.
Patent AU-2020265676-A1 (AU)
Title: Dosage regimens for and compositions including anti-RSV antibodies
Inventor: KHAN ANIS AHMED
IPC: A61P31/14
Filed: 2020-04-30
Abstract: In one aspect, this disclosure describes methods of treating or preventing RSV infection in a patient in need thereof. The methods including dosing regiments for administering a composition including a fixed dose of an anti-RSV monoclonal antibody or an antigen binding fragment thereof. In another aspect, this disclosure describes pharmaceutical compositions for the treatment or prevention of RSV infection. In yet another aspect, this disclosure describes a pharmaceutical unit dose including nirsevimab.
Patent AU-2020286280-A1 (AU)
Title: Bendamustine Pharmaceutical Compositions
Inventor: VOUDOURIS VASILIOS
IPC: A61K31/4184
Filed: 2020-12-10
Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine suitable for 
pharmaceutical use. Also provided are methods of producing dry-powder bendamustine. The 
pharmaceutical formulations can be used for any disease that is sensitive to treatment with 
bendamustine, such as neoplastic diseases.
Patent AU-2020294326-A1 (AU)
Title: Heterodimeric proteins
Inventor: MOORE GREGORY
IPC: C07K16/46
Filed: 2020-12-24
Abstract: C:\Interwoen\NRPortbl\DCC\AMT\18922900 _.doex-6/06/2019 
ABSTRACT 
In one aspect, the present invention provides heterodimeric antibodies comprising a first 
monomer comprising a first heavy chain constant domain comprising a first variant Fc 
domain and a first antigen binding domain and a second monomer comprising a second 
heavy chain constant domain comprising a second variant Fc domain and a second antigen 
binding domain. In an additional aspect the heterodimeric antibody comprises a first 
monomer comprising a heavy chain comprising a first Fc domain and a single chain Fv 
region (scFv) that binds a first antigen, wherein the scFv comprises a charged scFv linker.  
The heterodimeric antibody further comprises a second monomer comprising a first heavy 
chain comprising a second Fc domain and a first variable heavy chain and a first light 
chain.
WO2014/145806 PCT/US2014/030634 
183/183 
FIGURE 57E 
XENP13708 H1.86 L1.55 
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRF 
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYCSWFAYWGQGTLVTVSSGGGGSGGGGSGGGGS 
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNCRAPGVPARFSGSLLG 
GKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVLGSHHHHHH 
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRF 
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYCSWFAYWGQGTLVTVSSGGGGSGGGGSGGGGS 
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNCRAPGVPARFSGSLLG 
GKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVL 
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRF 
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYCSWFAYWGQGTLVTVSS 
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNCRAPGVPARFSGSLLG 
GKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVL 
XENP13709 H1.83 Ll.56 
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRF 
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYVSWFCYWGQGTLVTVSSGGGGSGGGGSGGGGS 
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNKRCPGVPARFSGSLLG 
GKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVLGSHHHHHH 
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRF 
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYVSWFCYWGQGTLVTVSSGGGGSGGGGSGGGGS 
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNKRCPGVPARFSGSLLG 
GKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVL 
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMNWVRQAPGKGLEWVGRIRSKYNNYATYYADSVKGRF 
TISRDDSKNTLYLQMNSLRAEDTAVYYCVRHGNFGDSYVSWFCYWGQGTLVTVSS 
QAVVTQEPSLTVSPGGTVTLTCGSSTGAVTTSNYANWVQQKPGKSPRGLIGGTNKRCPGVPARFSGSLLG 
GKAALTISGAQPEDEADYYCALWYSNHWVFGGGTKLTVL 
XENP VHID VLID Yield (mg/L) Tm(°C) 
12912 H1.79 L1.48 2.70 71.0
Patent AU-2020324822-A1 (AU)
Title: Notification method of continuous glucose monitoring system
Inventor: KANG BO WEOL
IPC: A61B5/145
Filed: 2020-03-13
Abstract: The present invention relates to a notification method of a continuous glucose monitoring system. A notification method of a continuous glucose monitoring system, according to one embodiment of the present invention, may comprise the steps of: performing a communication connection between a body attachment unit and a communication terminal for the communication terminal to receive blood glucose data measured from the body attachment unit which is attached to a human body and continuously measures blood glucose; transmitting information on the body attachment unit from the body attachment unit to the communication terminal and calculating a remaining use period of the body attachment unit; and generating, in the communication terminal, a notification on the remaining use period of the body attachment unit. According to the present invention, as the notification for the remaining period of the body attachment unit is generated in the communication terminal, there is an effect wherein a user can prepare in advance a body attachment unit to be replaced before the use period of the body attachment unit ends.
Patent AU-2020331882-A1 (AU)
Title: Isolated modified VP1 capsid protein of AAV5
Inventor: STRELKOVA ANNA NIKOLAEVNA
IPC: C12N15/861
Filed: 2020-08-21
Abstract: The present application relates to the field of gene therapy and molecular biology. More particularly, the present invention relates to an isolated modified VP1 capsid protein of adeno-associated virus serotype 5 (AAV5), which contains one or more amino acid substitutions by comparison with VP1 capsid protein of wild-type AAV5, which improve transduction efficiency, and also to a capsid and to a vector based thereon.
Patent AU-2020338412-A1 (AU)
Title: Push and twist mechanism for interfacing a drive mechanism handpiece with an intraocular lens cartridge
Inventor: WU YINGHUI
IPC: A61F2/16
Filed: 2020-08-21
Abstract: Systems, methods, and apparatuses for inserting an intraocular lens (IOL) into an eye, are provided. An apparatus comprises an IOL cartridge comprising a nozzle, a compartment, and a plunger case. The nozzle is in fluid communication with the compartment, and the plunger case is in fluid communication with the compartment. The plunger is disposed within the plunger case. The plunger case is configured to removably attach to a handpiece.
Patent AU-2020358755-A1 (AU)
Title: Connector
Inventor: STUMPE TOBIAS
IPC: A61M5/142
Filed: 2020-09-30
Abstract: The present disclosure relates to a connector for an infusion set. The connector comprises a body and at least one arm connected to the body which is configured to couple with a base of an infusion set; wherein the body has a first portion and a second portion which are configured to be removably and replaceably coupled together; and wherein each portion has a fluid delivery conduit, the conduits being configured to allow fluidic communication of the connector with at least two independent fluid sources. Also disclosed is an infusion set.
Patent AU-2020364150-A1 (AU)
Title: Targeted treatment of cancers with dysregulated fibroblast growth factor receptor signaling
Inventor: STRUM JAY COPELAND
IPC: A61P35/00
Filed: 2020-10-09
Abstract: The present invention provides advantageous methods and compositions for treating a host having a cancer with dysregulation of the FGFR signaling pathway, which includes administering an effective amount of a selective CDK4/6 inhibitor described herein in combination or alternation with a fibroblast growth factor receptor inhibitor.
Patent AU-2020377028-A1 (AU)
Title: SO2 adsorption material, preparation method therefor and application thereof, and method for removing SO2 from flue gas containing SO2
Inventor: WANG PENG
IPC: B01J20/22
Filed: 2020-10-27
Abstract: The present invention relates to the field of desulfurization, and disclosed are an SO
Patent AU-2020377914-A1 (AU)
Title: Peripherally acting cannabidiol(CBD)-containing compositions and uses thereof for enhancing female sexual function or treating female sexual disorders
Inventor: FRID MICHAEL
IPC: A01N31/16
Filed: 2020-11-03
Abstract: The present disclosure provides peripherally acting cannabidiol (CBD)-containing compositions and methods of using thereof for treating or enhancing female sexual function. In some embodiments, the compositions are provided in the form of a lotion, containing highly CBD-loaded liposomes, which is applied to female genitalia shortly prior to sexual activity.
Patent AU-2020400345-A1 (AU)
Title: Anaphora resolution
Inventor: ISHIKAWA SHUNSUKE
IPC: G10L15/18
Filed: 2020-12-04
Abstract: A method, a structure, and a computer system for resolving an anaphora. The exemplary embodiments may include extracting individual context data from an individual expression and determining whether the individual expression includes an anaphora representation based on the individual context data. The exemplary embodiments may further include, based on determining that the individual expression includes the anaphora representation, extracting anaphora context data and identifying an object of one or more objects to which the anaphora representation refers based on comparing the individual context data and the anaphora context data to data detailing the one or more objects.
Patent AU-2020416346-A1 (AU)
Title: Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases, comprising same
Inventor: YANG BO GIE
IPC: A61K35/747
Filed: 2020-12-29
Abstract: The present invention relates to a novel Lactobacillus fermentum strain (accession number: KCTC 14106BP), and a composition for preventing or treating metabolic diseases, comprising same. Lactobacillus fermentum of the present invention can inhibit fat accumulation and increase anti-inflammatory cells in white adipose tissues, and can effectively inhibit fat accumulation in brown adipose tissues and liver tissues. The Lactobacillus fermentum strain exhibits the excellent effect of lowering blood glucose and, particularly, can reduce fasting blood glucose levels, and can effectively improve insulin resistance by improving glucose tolerance and increasing insulin sensitivity. Therefore, the Lactobacillus fermentum strain can be effectively used in the prevention or treatment of metabolic diseases such as obesity.
Patent WO-2022109677-A1 (WO)
Inventor: RODNE LEE ERIC
IPC: A61K31/5517
Filed: 2021-11-26
Abstract: The present invention relates to pharmaceutical compositions comprising flumazenil and naltrexone, especially compositions comprising low-dose flumazenil and low-dose naltrexone. The present invention also relates to methods for the use of a combination of flumazenil and naltrexone in the treatment of depression and/or anxiety and/or post-traumatic stress disorder (PTSD).
Patent AU-2021200219-A1 (AU)
Title: System and method for creating and distributing multimedia content
Inventor: SHICHMAN DANIEL
IPC: H04N21/234
Filed: 2021-01-14
Abstract: A system and method may analyze an input video content to produce analysis results. An 
event captured in the input video content may be identified based on the analysis results. A start 
time and an end time of a segment of the input video content, the segment including the event, 
may be determined and, an output video content may be generated by including the segment in 
the output video content.  
68
Patent AU-2021200997-A1 (AU)
Title: Ocular formulations for drug-delivery and protection of the anterior segment of the eye
Inventor: BINGAMAN DAVID P
IPC: A61K9/10
Filed: 2021-02-16
Abstract: The present application relates to topical formulations comprising Compound-I 
or its free base, and a second active agent selected from nicotinic acid, nicotinamide, and 
vitamin K, and a combination thereof, for treating ocular neovascularization. The present 
application also relates to pharmaceutical compositions comprising particles of Compound-I 
or its free base, and suspension formulations compring the particle compositions of 
Compound-I or its free base.  
152